Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Proceedings

Open Access

The early protective innate immune response against West Nile virus

  • Stephane Daffis1,
  • Melanie A Samuel1,
  • Mehul S Suthar2,
  • Brian K Keller2,
  • Michael GaleJr2 and
  • Michael S Diamond1Email author
BMC Proceedings20082(Suppl 1):S8

https://doi.org/10.1186/1753-6561-2-s1-s8

Published: 23 September 2008

The type I interferon (IFN)-α/β response plays an essential role in controlling West Nile virus (WNV) tropism, replication and spread to the central nervous system (CNS) in mice. Induction of IFN-α/β relies on the detection of viruses by specific host factors known as pattern-recognition receptors. Central to this signaling pathway are the transcription factors interferon regulatory factors (IRF)-3 and IRF-7, which induce IFN-α/β gene expression. We used IRF-3-/-, IRF-7-/- and IRF-3-/- × IRF-7-/- mice to define how a deficiency of master innate immune response transcriptional factors impacts WNV pathogenesis and IFN signaling responses. Whereas WNV-infected wild type mice exhibited 35% mortality, mice lacking IRF-3 and/or IRF-7 had 100% mortality with enhanced viral burdens in peripheral and CNS organs, with altered tissue and cellular tropism. A deficiency in IRF-3 did not alter the systemic IFN response in vivo or IFN-α/β production ex vivo in immune cells. However, IRF-3 restricted WNV replication in macrophages by regulating basal expression of host defense molecules. Moreover, IRF-3 regulated WNV replication through IFN-dependent mechanisms in neurons. In contrast, an absence of IRF-7 abolished the systemic IFN production in mice and abrogated IFN-α responses in primary cells with little effect on IFN-β induction. Notably, a combined deficiency of IRF-3 and IRF-7 sustained enhanced WNV replication in vivo and in primary cells but did not completely abolish the IFN-b responses. These data show an essential role of IRF-3 and IRF-7 in the early control of WNV infection by regulating not only IFN responses but also antiviral programs in a cell/tissue-specific manner.

Authors’ Affiliations

(1)
Washington University School of Medicine
(2)
University of Washington School of Medicine

Copyright

© Daffis et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd.

Advertisement